Headlands Technologies’s ARK Genomic Revolution ETF ARKG Stock Holding History

Headlands Technologies’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,149	Closed	-$44.6K	–	1170
2025 Q1	$44.6K	Buy	+2,149	New	+$54K	0.01%	735
2024 Q3	–	Sell	-21,163	Closed	-$497K	–	1172
2024 Q2	$497K	Buy	21,163 +20,809	+5,878%	+$525K	0.05%	278
2024 Q1	$10.2K	Buy	+354	New	+$10.6K	﹤0.01%	1026
2023 Q2	–	Sell	-3,653	Closed	-$110K	–	780
2023 Q1	$110K	Buy	+3,653	New	+$113K	0.07%	174

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Headlands Technologies's ARKG Position: Q2 2025 in Review

Headlands Technologies sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 2,149 shares — an estimated $44.6K sold.

Headlands Technologies first reported a position in ARKG in Q1 2023 and held it in 4 quarters. The position peaked at $497K in Q2 2024. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

Headlands Technologies reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
Headlands Technologies sold 2,149 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $44.6K.
Headlands Technologies first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 4 quarters.
Headlands Technologies's ARK Genomic Revolution ETF position peaked at $497K in Q2 2024.
213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on Headlands Technologies's 13F filing for Q2 2025, filed 14 Aug 2025.